
51 - 200 employés
Fondée en 2019
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Definium Therapeutics est une entreprise de biotechnologie en phase clinique qui développe des thérapeutiques dérivées de substances psychédéliques pour des troubles psychiatriques et neurodéveloppementaux. La société se concentre sur des formulations pharmaceutiquement optimisées de lysergide (LSD) et un énantiomère R de MDMA pour traiter des conditions telles que le trouble dépressif majeur, le trouble anxieux généralisé, et les symptômes principaux du trouble du spectre autistique, faisant progresser les candidats à travers les essais précliniques et cliniques avec une approche dirigée par la science et soutenue par des preuves.
🕒 il y a 3 jours
🇺🇸 États-Unis – Télétravail
💵 $230 000 - $320 000 / an
⏰ Temps Plein
🟠 Senior
👔 Directeur
👻 Score fantôme 2%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Definium Therapeutics, pas via un site d'emploi
Repérée par Remote Rocketship il y a 3 jours
Toujours ouverte sur le site de Definium Therapeutics. Vérifiée il y a 1 heure.

51 - 200 employés
Fondée en 2019
🏥 Santé
🧬 Biotechnologie
💊 Pharmaceutique
Healthcare • Biotechnology • Pharmaceuticals
Definium Therapeutics est une entreprise de biotechnologie en phase clinique qui développe des thérapeutiques dérivées de substances psychédéliques pour des troubles psychiatriques et neurodéveloppementaux. La société se concentre sur des formulations pharmaceutiquement optimisées de lysergide (LSD) et un énantiomère R de MDMA pour traiter des conditions telles que le trouble dépressif majeur, le trouble anxieux généralisé, et les symptômes principaux du trouble du spectre autistique, faisant progresser les candidats à travers les essais précliniques et cliniques avec une approche dirigée par la science et soutenue par des preuves.
• Define an enterprise digital innovation strategy aligned with Definium’s 3–5 year growth and commercialization plans • Assess digital capabilities, platforms, vendors, consultants, AI initiatives, and spending; identify gaps, overlap, underutilization, and simplification opportunities • Build and maintain a prioritized multi-year roadmap based on business value, readiness, risk, and scalability • Benchmark emerging practices across biotech, specialty pharma, and adjacent industries • Define capabilities for launch readiness and post-launch operations with Commercial, Market Access, Patient Services, Medical Affairs, and Enterprise Technology • Shape digital patient and provider experiences supporting patient services, reimbursement, engagement, adherence, and omnichannel interactions • Strengthen analytics and decision support for commercialization leadership • Identify and prioritize high-value AI, automation, and emerging digital opportunities • Establish responsible, secure, and sustainable adoption of new capabilities with Technology, Legal, Compliance, Privacy, and business stakeholders • Clarify decision rights and establish governance for intake, prioritization, architecture, vendors, investments, and value realization • Determine build-versus-source strategy; manage consultants and vendors and evolve the internal team • Advise senior leaders, translate business problems into capability and technology requirements, and explain technical choices to non-technical stakeholders • Drive cross-functional alignment, adoption, and change
• 12+ years of relevant experience spanning digital strategy, enterprise technology, product, data/analytics, or technology-enabled business transformation, ideally within biotechnology, pharmaceuticals, or another regulated industry • Experience leading digital strategy or transformation programs connecting enterprise technology with business functions • Experience supporting a company approaching commercialization or launch is highly valued • Working knowledge of commercial life sciences capabilities, particularly patient services, market access, omnichannel engagement, commercial analytics, and related data flows • Exposure to Clinical and Medical Affairs is a plus • Ability to evaluate and apply AI, automation, data, and emerging technologies to business problems • Experience developing roadmaps, business cases, operating models, governance, and investment priorities • Strong vendor and partner management skills, including build-versus-buy-versus-partner judgment • Exceptional cross-functional leadership and communication skills, with ability to influence senior stakeholders without direct authority • Comfort operating in a fast-growing environment with ambiguity and competing priorities • Bachelor’s degree required; advanced degree or relevant technical/business training is a plus
• Bonus opportunities • Equity opportunities • Health insurance • 401(k) with company match • Flexible time off • Wellness benefits and perks
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 3 jours
Associate Director leading PMO governance and program controls for Turner & Townsend’s aviation and infrastructure programs. Overseeing cost, schedule, risk, reporting, and executive stakeholder alignment.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Associate Director leading pharmacokinetics and pharmacodynamics for Atrium’s RNA therapeutics. Advancing genetic cardiomyopathy programs through PKPD strategy, bioanalysis, and regulatory support.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Associate Director shaping CNS Medical Affairs strategy for Otsuka pharmaceutical assets. Leading evidence generation, scientific communications, cross-functional execution, and strategic content review.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
US Oncology Patient Channel Strategist shaping data-driven media strategies for Merck’s medicines and vaccines. Guiding targeting, measurement, optimization, and patient marketing performance.
🇺🇸 États-Unis – Télétravail
💵 $156 900 - $247 000 / an
⏰ Temps Plein
🟠 Senior
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 3 jours
Senior Director building Coca-Cola Consolidated’s integrated beverage commercial execution system. Connecting strategy, bottler adoption, field execution, and marketplace growth.
🗣️🇺🇸🇬🇧 Anglais requis